Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON

: Therapielinie 3 – adjuvante Immuntherapie (Pembrolizumab), ambulant

Raw xml | Download

<EpisodeOfCare xmlns="http://hl7.org/fhir">
  <id value="TherapieliniePembroAdjuvant"/>
  <meta>
    <profile
             value="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-line"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: EpisodeOfCare TherapieliniePembroAdjuvant</b></p><a name="en-TherapieliniePembroAdjuvant"> </a><a name="en-hcTherapieliniePembroAdjuvant"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-onko-therapy-line.html">Onkologische Therapielinie</a></p></div><blockquote><p><b>Onkologische Therapieintention (Extension)</b></p><ul><li>hauptintention: <span title="Codes:{http://snomed.info/sct 373846009}">Adjuvant - intent</span></li><li>phase: <span title="Codes:{http://snomed.info/sct 1345242003}">Maintenance antineoplastic therapy</span></li></ul></blockquote><p><b>EnLiST-Linien-Segment (Extension)</b>: <code>https://bih-cei.de/fhir/therapieziele-onkologie/sid/enlist-line</code>/mamma-baumann-elot-1</p><p><b>EnLiST-Zählstatus (Extension)</b>: <span title="Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-countable counted}">Zählt in der LoT-Zählung</span></p><p><b>Therapielinie – Medikationsverordnung (Extension)</b>: <a href="MedicationRequest-MedicationRequestPembroAdjuvantMamma.html">MedicationRequest: extension = Same LoT; status = active; intent = plan; category = Tumor board Consult note; medication[x] = </a></p><p><b>status</b>: Active</p><p><b>type</b>: <span title="Codes:{http://snomed.info/sct 76334006}">Ambulante adjuvante Immuntherapie – Pembrolizumab-Monotherapie</span></p><h3>Diagnoses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Condition</b></td><td><b>Role</b></td><td><b>Rank</b></td></tr><tr><td style="display: none">*</td><td><a href="Condition-ConditionMamma.html">Condition Bösartige Neubildung: Oberer äußerer Quadrant der Brustdrüse</a></td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/diagnosis-role CC}">Chief complaint</span></td><td>1</td></tr></table><p><b>patient</b>: <a href="Patient-PatientinMamma.html">Sabine Baumann  Female, DoB: 1977-06-24</a></p><p><b>managingOrganization</b>: <a href="Organization-Tumorboard.html">Organization Zertifiziertes Brustzentrum Musterklinik</a></p><p><b>period</b>: 2026-04-24 --&gt; (ongoing)</p><p><b>careManager</b>: <a href="Practitioner-OnkologinMamma.html">Practitioner Katrin Musterarzt </a></p></div>
  </text>
  <extension
             url="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-intent">
    <extension url="hauptintention">
      <valueCodeableConcept>
        <coding>
          <system value="http://snomed.info/sct"/>
          <code value="373846009"/>
          <display value="Adjuvant - intent"/>
        </coding>
      </valueCodeableConcept>
    </extension>
    <extension url="phase">
      <valueCodeableConcept>
        <coding>
          <system value="http://snomed.info/sct"/>
          <code value="1345242003"/>
          <display value="Maintenance antineoplastic therapy"/>
        </coding>
      </valueCodeableConcept>
    </extension>
  </extension>
  <extension
             url="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-line-segment">
    <valueIdentifier>
      <system
              value="https://bih-cei.de/fhir/therapieziele-onkologie/sid/enlist-line"/>
      <value value="mamma-baumann-elot-1"/>
    </valueIdentifier>
  </extension>
  <extension
             url="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-countable">
    <valueCodeableConcept>
      <coding>
        <system
                value="https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-countable"/>
        <code value="counted"/>
        <display value="Zählt in der LoT-Zählung"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-line-medication-request">
    <valueReference>🔗 
      <reference
                 value="MedicationRequest/MedicationRequestPembroAdjuvantMamma"/>
    </valueReference>
  </extension>
  <status value="active"/>
  <type>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="76334006"/>
      <display value="Immunological therapy"/>
    </coding>
    <text
          value="Ambulante adjuvante Immuntherapie – Pembrolizumab-Monotherapie"/>
  </type>
  <diagnosis>
    <condition>🔗 
      <reference value="Condition/ConditionMamma"/>
    </condition>
    <role>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/diagnosis-role"/>
        <code value="CC"/>
        <display value="Chief complaint"/>
      </coding>
    </role>
    <rank value="1"/>
  </diagnosis>
  <patient>🔗 
    <reference value="Patient/PatientinMamma"/>
  </patient>
  <managingOrganization>🔗 
    <reference value="Organization/Tumorboard"/>
  </managingOrganization>
  <period>
    <start value="2026-04-24"/>
  </period>
  <careManager>🔗 
    <reference value="Practitioner/OnkologinMamma"/>
  </careManager>
</EpisodeOfCare>